Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release
NCT07115901 is an interventional trial sponsored by University of California, San Francisco. As of 21 Nov 2026, it is active and no longer recruiting. It studies HIV (Human Immunodeficiency Virus). The registry lists an enrollment of 33 participants at 1 site in 1 country. The registry lists a start date of 1 Dec 2025 and a primary completion date of 25 Feb 2027.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT07115901 |
| Status | Active not recruiting |
| Study type | Interventional trial |
| Lead sponsor | University of California, San Francisco |
| Enrollment | 33 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | HIV (Human Immunodeficiency Virus) |
| Start | 1 Dec 2025 |
| Primary completion | 25 Feb 2027 |
| Study completion | 25 Feb 2027 |
| Last update posted | 9 Jun 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Paul D Wesson, PhD
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Francisco
San Francisco
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT07115901
Each answer restates registry values shown on this page.
What is NCT07115901?
NCT07115901 is an interventional trial sponsored by University of California, San Francisco. It studies HIV (Human Immunodeficiency Virus).
Is NCT07115901 recruiting?
As of 21 Nov 2026, it is active and no longer recruiting.
Who leads NCT07115901?
The registry names Paul D Wesson, PhD (principal investigator, University of California, San Francisco) as the overall official.
Where does NCT07115901 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT07115901 expected to complete?
The registry lists a primary completion date of 25 Feb 2027 and a study completion date of 25 Feb 2027. The sponsor last updated the record on 9 Jun 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.